Mercer Global Advisors
VYGR icon

Mercer Global Advisors’s Voyager Therapeutics VYGR Stock Holding History

Mercer Global Advisors’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.6K Buy
+7,607
New +$28.8K ﹤0.01% 4672

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Mercer Global Advisors's VYGR Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Voyager Therapeutics (VYGR) in Q2 2026: 7,607 shares worth $26.6K. The stake represents ﹤0.01% of the portfolio and ranks #4672 among its holdings.

114 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Mercer Global Advisors held 7,607 shares of Voyager Therapeutics worth $26.6K as of Q2 2026.
  • Voyager Therapeutics was a new Mercer Global Advisors position in Q2 2026.
  • Voyager Therapeutics made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #4672 holding.
  • 114 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.